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ABSTRACT 
 
The aim of this study was to investigate the effect of citric acid or the sweetening agent aspar-
tame on the CCl4-induced hepatic injury in rats. Citric acid (10 mg/kg, 100 mg/kg or 
1000 mg/kg), aspartame (0.625 or 1.25 mg/kg) or silymarin (25 mg/kg) was given once daily 
orally simultaneously with CCl4 and for one week thereafter. The administration of citric acid 
at 100 mg/kg or 1000 mg/kg to CCl4-treated rats reduced elevated plasma ALT by 44.1-
63.3 %, AST by 47.8-70.6 %, ALP by 41.7-67.2 %, respectively compared to controls. Aspar-
tame at 0.625 or 1.25 mg/kg reduced plasma ALT by 39.8-52.0 %, AST by 43.2-52.4 % and 
ALP by 50.0-68.5 %, respectively. Meanwhile, silymarin at 25 mg/kg reduced ALT, AST and 
ALP levels by 52.7, 62.2 and 64.7 %, respectively. On histology, citric acid at 1000 mg/kg 
resulted in near normalization of liver tissue. Vacuolar degeneration and necrosis were mark-
edly reduced by 1.25 mg/kg aspartame. These results indicate that treatment with citric acid or 
the sweetening agent aspartame protects against hepatocellular necrosis induced by CCl4.  
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INTRODUCTION 
 
Citric acid, 2-hydroxy-1,2,3-propane-
tricarboxylic acid, is a weak organic acid 
found in the greatest amounts in citrus fruits 
such as lemon, grapefruit, tangerine and 
orange. It is an intermediary substance in 
oxidative metabolism, being a component 
of the tricarboxylic acid cycle. Citric acid is 
used as a natural preservative and also to 
add an acidic (sour) taste to foods and soft 
drinks (Grigor et al., 2002). Citric acid pos-
sesses sensory properties that is, when ap-
plied to the tip of the tongue in human sub-
jects, citric acid produced taste sensations 
and also irritation which are mediated via 
capsaicin-sensitive fibers since reductions 
in irritation and taste occurred following 
treatment with capsaicin (Gilmore and 
Green, 1993). Citric acid applied to the dor-
sal surface of the tongue in human at the 
concentration of 250 mM caused irritation 
which involves acid-sensitive ion channels 
and vanilloid receptors (Dessirier et al., 
2000). In awake, behaving rats, intraoral 
infusions of 0.1 M citric acid elicited Fos-
like immunoreactivity in the nucleus of the 
solitary tract that receives input from 
orosensory afferents and also in a location 
that mainly receives primary afferent input 
from the vagus nerve. These results suggest 
that strong gustatory stimuli can influence 
visceral afferent systems (Travers, 2002). It 
has been shown that gustatory and other 
oral sensory signals can trigger neural re-
flexes (Horio, 2000). In a previous study, 
citric acid introduced into the stomach of 
mice at increasing concentrations of 
4.8 µM-0.48 mM, resulted in inhibition of 
the nociceptive behavior induced by subse-
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quent acetic acid injection into the perito-
neal cavity. This phenomenon is also seen 
when sucrose solution was intragastrically 
given, which suggested that a number of 
noxious and gustatory stimuli interfere with 
processing of noxious visceral stimulation 
at a distant site in the gastrointestinal tract 
(Abdel-Salam and Baiuomy, 2008). The 
dipeptide aspartame (N-L-alpha-aspartyl-L-
phenylalanine, 1-methyl ester; alpha-APM) 
is a widely consumed artificial sweetener. 
Sweet taste information results in c-Fos ex-
pression in the nucleus of the solitary tract 
(Streefland et al., 1996) and central trans-
mission of sweetness information elicits 
insulin release (Tonosaki et al., 2007). In 
light of the above the present study was de-
signed to test whether oral administration of 
citric acid or the low-calorie sweetener as-
partame would modulate the hepatic dam-
age produced by the hepatotoxin CCl4 in 
rats.  
 
MATERIALS AND METHODS 
Animals 
Adult Sprague-Dawley rats of either 
sex, weighing 120 g (age: 10 weeks) were 
used throughout the experiments and fed 
with standard laboratory chow and water ad 
libitum. Animal procedures were performed 
in accordance with the Ethics Committee of 
the National Research Centre and followed 
the recommendations of the National Insti-
tutes of Health Guide for Care and Use of 
Laboratory Animals (Publication No. 85-
23, revised 1985). 
 
Drugs and chemicals  
Carbon tertrachloride (BDH Chemicals, 
England), citric acid, aspartame (Sigma, St. 
Louis, USA) and silymarin (SEDICO, 
ARE), were used in the experiments. The 
doses for rats used were equivalent to the 
human dose according to Paget and Barnes 
(1964) conversion tables. 
 
The carbon tetrachloride model of hepatic 
damage 
The rats were divided into 8 equal 
groups, 6 rats each. Groups 1-7, received 
CCl4 in olive oil (1:1, vol/vol) at a dose of 
2.8 ml/kg through orogastric tube. Starting 
on the first day of CCl4 administration, rats 
were treated with citric acid (10 mg/kg, 
100mg/kg, 1000 mg/kg, 1.25 ml, p.o.), as-
partame (0.625 or 1.25 mg/kg, 0.25 ml, 
p.o.), silymarin (25 mg/kg) or saline once 
daily orally and for 7 days thereafter. All 
treated rats were administered half the ini-
tial dose of CCl4, 3 days after the first ad-
ministration of CCl4 so as to maintain he-
patic damage. In addition, an 8th group of 
rats (n = 6) received the vehicle (olive oil) 
at 2.8 ml/kg followed 3 days later by an ad-
ditional dose of 1.4 ml/kg olive oil. Rats 
had free access to food and drinking water 
during the study. After 7 days of CCl4 or 
olive oil administration, rats were killed by 
cervical dislocation after being anaesthe-
tized with ether. 
 
Biochemical assessment 
At the end of the experiments, blood 
samples were obtained from the retro-
orbital vein plexus, under ether anaesthesia.  
ALT and AST activities in serum were 
measured according to Reitman-Frankel 
colorimetric transaminase procedure 
(Crowley, 1967), whereas colorimetric de-
termination of ALP activity was done ac-
cording to the method of Belfield and 
Goldberg (1971), using commercially 
available kits (BioMérieux, France). 
 
Histological and histochemical studies 
Livers of all animals were dissected 
immediately after death. The specimens 
were then fixed in 10 % neutral-buffered 
formalin saline for 72 hours at least. All the 
specimens were washed in tap water for 
half an hour and then dehydrated in ascend-
ing grades of alcohol, cleared in xylene and 
embedded in paraffin. Serial sections of 
6 µm thick were cut and stained with 
haematoxylin and eosin for histopathologi-
cal investigation. Images were captured and 
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processed using Adobe Photoshop version 
8.0. 
 
Statistical analysis 
All results are expressed as mean ± SE. 
Comparison of the values before and after 
CCl4 was made by paired Student's t-test. 
Multiple group comparisons were per-
formed by ANOVA followed by Duncan 
test. P < 0.05 was considered statistically 
significant. 
 
RESULTS 
 
Biochemical changes 
In rats treated with CCl4, the levels of 
alanine aminotransferase (ALT), aspartate 
aminotransferase (AST) and alkaline phos-
phatase (ALP) in plasma were markedly 
raised by 227.1 % (181.7 ± 13.6 vs 80.3 ± 
6.8 U/l), 265.7 % (188.4 ± 11.0 vs 71.0 ± 
4.0 U/l) and 289.2 % (147.5 ± 10.1 vs 51.9 
± 2.8 U/l), indicating the severity of hepatic 
injury caused by CCl4. Citric acid given at 
time of CCl4 administration at doses of 
10 mg/kg did not significantly alter the 
plasma enzyme levels. The administration 
of citric acid at 100 mg/kg or 1000 mg/kg 
to CCl4-treated rats reduced the elevated 
plasma ALT by 44.1-63.3 %, AST by 47.8-
70.6 %, ALP by 41.7-67.2 %, respectively 
compared to controls. Aspartame at 0.625 
or 1.25 mg/kg reduced plasma ALT by 
39.8-52.0 %, AST by 43.2-52.4 %, ALP by 
50.0-68.5 %, respectively. Silymarin treat-
ment at 25 mg/kg reduced the levels of 
ALT, AST and ALP by 52.7, 62.2 and 
64.7 %, respectively (Table 1). 
 
Histological findings 
The liver of control rats revealed the 
normal characteristic architecture (Fig. 1A, 
B). The liver tissue of rats treated with CCl4 
only, showed congestion of central veins, 
dilatation and congestion of portal vein and 
fibrosis (Fig. 1C, D). The liver tissue from 
rats treated with citric acid (10 mg/kg) and 
CCl4, still exhibited dilatation and conges-
tion of both portal and central vein as well 
as the fibrosis (Fig. 2A, B). Examination of 
liver sections from rats given citric acid in a 
dose of 100 mg/kg revealed normal size and 
shape of the central vein and there was 
marked reduction of dilatation and conges-
tion of the portal vein. Figure 2 E & F show 
the effect of citric acid administered at the 
dose of 1000 mg/kg, where normalization 
of liver tissue is observed. 
 
 
 
Table 1: Effect of citric acid or aspartame on serum alanine aminotransferase (ALT), aspartate amino-
transferase (AST) and alkaline phosphatase (ALP) in CCl4-treated rats 
 
 Vehicle CCl4  
(control) 
CCl4 + 
citric acid  
10 mg/kg 
CCl4 + 
citric acid 
100 
mg/kg 
CCl4 + 
citric 
acid 
1000 
mg/kg 
CCl4 +  
aspartame 
0.625 mg/kg 
CCl4 +  
aspartame  
1.25 mg/kg 
CCl4 +  
silymarin  
25 mg/kg 
ALT 
(U/l) 
71.0 ± 4 188.4 ± 11.0 
 
 
159.3 ± 
8.6 
98.4 ± 
6.1*+# 
 
55.5 ± 
4.9*+ 
 
107.1 ± 6.9*+# 89.7 ± 5.6*+ 71.2 ± 5.4*+ 
AST 
(U/l) 
80.3 ± 6.3 181.7 ± 13.6 
 
 
169.0 ± 
12.6 
 
101.6 ± 
7.6*+ 
 
66.8 ± 
3.8*+ 
 
109.3 ± 7.6*+# 87.2 ± 6.2*+ 86.0 ± 4.5+* 
 
ALP 
(U/l) 
51.9 ± 2.8 147.5 ± 10.1 
 
 
133.9 ± 
10.8 
86.9 ± 
5.6*+# 
 
48.6 ± 
4.7*+ 
 
74.0 ± 6.0*+# 46.3 ± 4.3*+ 51.9 ± 5.0*+ 
 
*: p<0.05 vs CCl4 control group; +: p<0.05 vs CCl4 + citric acid 10 mg/kg-treated group; #:p<0.05 vs silymarin-
treated group or vs CCl4 + citric acid 1000 mg/kg-treated group 
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Figure 1 (a, b): A photomicro-
graph of a section of liver tissue 
showing the normal structure of 
liver tissue, where the cells are 
arranged in cords radiating 
from the central vein (c) forming 
the classic lobule without sharp 
demarcation between adjacent 
lobules; and  the cords of he-
pacytes that are of thickness of 
1-2 cells and separated from 
each other by equal-sized 
blood sinusoids. The lumens of 
these sinusoids contain blood 
cells and nuclei of kupffer cells 
(arrow). (c): A photomicrograph 
of a section of liver tissue of a 
control CCl4-treated rat, show-
ing congestion of central veins 
(CV), dilatation and congestion 
of portal vein (P) and fibrosis in the form of a septum extending from the portal area in the paren-
chyma of liver (arrow). The fibrous septum is composed mainly of collagenous fibers and fibrocytes 
(arrow). Some of the hepatocytes beside the septum show apoptosis (A). The normal architecture of 
the liver tissue is markedly disturbed (d). 
 
 
Figure 2: (A) A photomicro-
graph of a section of liver tissue 
from a rat treated with CCl4 and 
citric acid (10 mg/kg), showing 
that  dilatation and congestion 
of both portal and central vein 
are still present as well as the 
fibrosis especially at the portal 
area extending from it outwards 
(arrow head). In section (B) 
cellular infiltrates (arrow) are 
seen at the area of fibrosis, 
which is composed mainly of 
collagen fibers (arrow head). 
Section (C) shows the effect of 
citric acid at a dose of 
(100 mg/kg) where the central 
vein regains its normal size and 
shape (c) and there is marked 
reduction of dilatation and con-
gestion of portal vein (P). How-
ever, there is still fibrous tissue 
extending from the portal area 
(arrow head) and at the bound-
ary of the classic lobule (arrow). 
Section (D) is a higher magnifi-
cation of the previous section 
showing that the fibrous tissue 
is made up of collagenous fi-
bers and minimal cellular infil-
trate (arrow). Sections (E & F) show the effect of citric acid at the dose of 1000 mg/kg, where normali-
zation of liver tissue is observed, although there are remnants of fibrous tissue at the boundary of the 
lobules (arrow).  
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Figure 3A & B show a section of liver tis-
sue treated with aspartame at the dose of 
0.625 mg/kg and CCl4 showing necrosis, 
vacuolar degeneration and fibrosis. With 
the higher dose of 1.25 mg/kg of aspartame, 
hepatocyte degeneration and necrosis were 
markedly reduced (Fig. 3C & D).  
 
Discussion 
The present study provided the first evi-
dence that both the natural preservative and 
food additive citric acid and the artificial 
sweetener aspartame were able to lessen the 
degree of hepatocellular damage caused by 
CCl4 in rats. The release of hepatocelluar 
enzymes into blood was decreased and his-
tological indices of hepatocelluar injury 
were reduced by either agent in a dose-
dependent manner.  
 
Citric acid is used as a natural preservative 
and also to add an acidic (sour) taste to 
foods and soft drinks (Grigor et al., 2002). 
Citric acid possesses sensory properties. In 
the airways, citric acid excites C-fibres and 
mimic many of the effects of capsaicin, in-
cluding pain, bronchoconstriction, cough, 
and sensory neuropeptide release (Fox et 
al., 1993, 1995). In the oral cavity, the taste 
sensation caused by citric acid is mediated 
via capsaicin-sensitive fibers (Gilmore and 
Green, 1993; Geppetti et al., 1993; Dessir-
ier et al., 2000) and the responses of gusta-
tory neurons in the nucleus tractus solitarius 
to citric acid (0.03 M), decreased after lin-
gual application of capsaicin (Simons et al., 
2003). The gastrointestinal tract has rich 
sensory innervation comprising intrinsic 
sensory neurons contained entirely within 
the gastrointestinal wall, intestinofugal fi-
bres that project to prevertebral ganglia, and 
vagal and spinal afferents that project into 
the central nervous system. Afferent fibres 
convey sensory information from the upper 
gastrointestinal tract to the central nervous 
system via vagal and splanchnic nerve 
pathways (Grundy, 2002; Holzer et al., 
2005). In the meantime, local efferent 
mechanisms due to local release of neu-
ropeptides, eliciting enhancement of the 
local microcirculation and inhibition of gas-
tric acid secretion, account for the protec-
tive functions that sensory nerves subserve 
in the gastrointestinal tract (Abdel-Salam et 
al., 1999; Szolcsányi and Barthó, 2001.). 
Within the liver, sensory nerve fibers stimu-
late mechanisms of hepatic protection via 
an efferent release of neurotransmitters.  
 
 
 
 
 
Figure 3: (A) A photomicro-
graph of a section of liver tissue 
treated with CCl4 and aspar-
tame at the dose of 0.625 
mg/kg showing the presence of 
fibrous septa radiating from the 
portal area within the paren-
chyma of the hepatic lobule 
(arrow). Section (B) shows ne-
crosis and vacuolar degene-
ration in the hepatocytes at the 
boundary of the hepatic lobule 
(arrow). Sections (C & D) show 
the effect of aspartame at the 
dose of 1.25 mg/kg, where the 
fibrosis with mild cellular infil-
trate is still present (arrow), but 
the degeneration and necrosis 
is markedly reduced.  
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The rat hepatobiliary tract is densely inner-
vated by CGRP-containing fibers that form 
dense networks in the fibromuscular layer 
of the biliary tree and surrounding the por-
tal vein. This suggests the involvement of 
these peptidergic visceral afferents in regu-
lating hepatobiliary activities, including 
hemodynamic functions of the hepatic vas-
culature (Goehler and Sternini, 1996). In 
this context, it has been shown that orally 
administered capsaicin protected against the 
hepatotoxic effects of CCl4 in rats (Abdel-
Salam et al., 2006). Piperine which also ac-
tivates vanilloid receptors (Szolcsányi, 
1983; Liu and Simon, 1996) have been 
shown to protect against hepatocellular in-
jury and fibrosis caused in rats by bile duct-
ligation (Abdel-Salam et al., 2008). It could 
be that the sensation produced by citric acid 
or chemical excitation of nociceptors in the 
stomach by citric acid excite vagal neurons 
involved in signalling hepatic protection. 
Citrate absorption is rapid and efficient in 
man, with 96 to 98 % absorbed within 3 
hours (Fegan et al., 1992). Plasma citrate 
peaked after 32 min, returning to baseline 
by 90 min (Taylor et al., 1998). Whether 
citric acid can reach hepatobiliary tract and 
excite sensory nerve endings or prevent 
liver injury via antioxidant properties is not 
clear. Increased intracellular citrate synthe-
sis might also be involved. Bjarnason et al. 
(1992) have shown that the administration 
of glucose and citrate mitigated the increase 
in intestinal permeability caused by indo-
methacin, likely through stimulation of gly-
colysis and the tricarboxylic acid cycle.  
Gustatory stimuli, including bitter- and 
sour tasting chemicals, trigger cardiovascu-
lar and digestive reflexes (Yonemura  et al., 
1989; Hanamori and Ishiko, 1993; Horio, 
2000), and there are pathways from the ros-
tral to the caudal nucleus of the solitary 
tract that could mediate these actions 
(Beckman and Whitehead, 1991; Streefland 
and Jansen, 1999). In rats, sweet taste in-
formation induced by a single infusion of 
sucrose (intra-oral or intra-gastric) or sac-
charin (intra-oral) results in c-Fos expres-
sion in the nucleus of the solitary tract 
(Streefland et al., 1996). The expression of 
the immediate early gene c-Fos and subse-
quent synthesis of its Fos protein, is a 
marker of neuronal activity (Hunt et al., 
1987). Tasting food elicits the release of 
digestive enzymes, known as cephalic 
phase of digestion. The non-nutritive 
sweetener saccharine elicited insulin release 
prior to increasing plasma glucose levels 
and sweetness information conducted by 
chorda tympani appear to provide essential 
information for eliciting this cephalic phase 
of insulin release (Tonosaki et al., 2007). 
Gustatory and other oral sensory signals 
appear also to trigger neural reflexes. In 
human subjects, oral application of sucrose 
0.07, 0.28, 1.12 M or citric acid solutions 
0.002, 0.008, 0.032 M elicited an increase 
in heart rate within 5 sec that peaked 40 sec 
and declined in 801-100sec after applica-
tion (Horio, 2000). Taste cells responding 
to sweet or bitter taste stimuli secrete the 
neurotransmitter ATP which is believed to 
excite primary sensory afferent fibers that 
convey gustatory signals to the brain. This 
suggests that there is important information 
processing and signal coding taking place in 
the mammalian taste bud after gustatory 
stimulation (Roper, 2007). It is therefore 
possible that the observed hepatoprotective 
effect of citric acid or the sweetener aspar-
tame, represents gustatory activation of the 
afferent limb of visceral reflex circuits. Pro-
jections from somatosensory neurons 
throughout the oral cavity, and from vis-
ceral neurons in the gut, intermingle with 
gustatory neurons in the solitary neucleus 
(Whitehead and Frank, 1983) and gustatory 
cortex (Barnett et al., 1995), suggesting that 
interactions should occur between taste and 
other systems.  
Citric acid is found in all animal tissues 
as an intermediate in the Krebs cycle, and 
therefore no limit has been set on the ac-
ceptable daily intake for humans for either 
the acid or salt (German, 2002). Studies on 
citrate pharmacokinetics and metabolism in 
critically ill cirrhotic patients confirmed a 
major role of hepatic citrate metabolism by 
demonstrating reduced citrate clearance in 
EXCLI Journal 2009;8:41-49 – ISSN 1611-2156 
Received: January 31, 2009, accepted: February 23, 2009, published: February 26, 2009 
 
47 
cirrhotic patients, but without citrate-related 
side effects (Kramer et al., 2003). The ac-
ceptable daily intake levels of aspartame 
established by U.S. Food and Drug Admini-
stration and European Food Safety Author-
ity is 50 and 40 mg/kg/day, respectively 
(Magnuson et al., 2007). In the present 
study, the doses of aspartame used are no-
tably low.  In the body, aspartame is com-
pletely hydrolyzed into three metabolites: 
aspartic acid, phenylalanine, and methanol. 
All are naturally present in foods and the 
contribution to the total daily intake of each 
of these from aspartame is small to trivial 
(Magnuson et al., 2007). Studies in patients 
with chronic, alcoholic liver disease, sug-
gested that aspartame in a dose of 15 mg/kg 
(representing 5 times the average daily in-
take of adults) did not result in clinical de-
rangements in encephalopathic indices 
(Hertelendy et al., 1993). Studies in man 
also indicated that ingestion of dietary 
phenylalanine, as supplied in a single can of 
diet cola (providing 184 mg aspartame, of 
which 104 mg is phenylalanine), is readily 
handled in both normal and phenylketonu-
ric subjects (Stephanie et al., 1992). Aspar-
tame is not without effects on the central 
nervous system, but these occur only when 
high doses of the sweetener are adminis-
tered. In rats, acute doses of up to 2000 
mg/kg, failed to induce significant changes 
in brain serotonin or dopamine levels 
(Dailey et al., 1991), but rats given 200 
mg/kg of aspartame showed large incre-
ments in brain and plasma levels of 
phenylalanine and its product tyrosine, 
while mice given aspartame at 13, 130 and 
650 mg/kg, have increases of 12, 49 and 
47 % respectively in norepinephrine after 
3 hours in the hypothalamus and significant 
increases in norepinephrine in the medulla 
oblongata and corpus striatum (Coulombe 
and Sharma, 1986). 
In summary, the present study reports 
the observation that two gustatory stimuli 
namely citric acid and the sweetening agent 
aspartame have modulatory effect on the 
CCl4-induced hepatic injury in rats. 
Whether this is the result of an interaction 
of sour and sweet taste solutions with taste 
receptor cells on the dorsal surface of the 
tongue or due to stimulation of upper gas-
trointestinal mucosal afferents with the ac-
tivation of neuroendocrine or autonomic 
reflexes or the result of excitation of sen-
sory nerve endings within the liver remains 
to be established.  
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